In addition to immune checkpoints (PD-L1/L2, LAG3, TIM-3) strongly expressed IL1R2 and CD70 can inhibit immune responses and create a tolerogenic tumor microenvironment (TME) [41, 64]. This evidence concerns the gene HAVCR2 and neoplasm.